Shared decision-making is crucial, incorporating discussion of treatment goals, potential risks, expected benefits, cost considerations, and alternative options
Eleven brands across six molecules, made almost entirely by two companies Novo Nordisk and Eli Lilly: Semaglutide (Novo Nordisk) Ozempic, Wegovy, Rybelsus Tirzepatide (Eli Lilly) Mounjaro, Zepbound Liraglutide (Novo Nordisk) Victoza, Saxenda Dulaglutide (Eli Lilly) Trulicity Exenatide (AstraZeneca) Byetta, Bydureon BCise Lixisenatide (Sanofi) Adlyxin, no longer marketed in the US For weight management , the FDA has approved Wegovy, Zepbound and Saxenda
Blood pressure reduction: GLP-1 medications typically reduce systolic blood pressure by 4-6 mmHg
Individual responses to caffeine are affected by body size and composition, so folks with smaller bodies may prefer no caffeine
Vitamin injections can help with this deficiency